To examine the control of Axud1E1 accessibility, we performed ATAC-qPCR in embryos transfected with a TFAP2A morpholino. HH4 embryos were bilaterally injected with control and targeted morpholinos, as described previously. Embryos were incubated at 37°C until HH9, when dorsal neural folds were surgically dissected. Paired single neural folds were individually processed for DNA tagmentation following the ATAC protocol described in [17]. For each genomic location, specific enrichment was quantified by RT-PCR (S5 Table). Raw CT values were first normalized to a control region defined by the absence of transcription factor binding, no enrichment of active histone marks and low DNA accessibility in our CUT&RUN and ATAC datasets. Changes in chromatin accessibility in morpholino treated samples were subsequently compared to control samples.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.